Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | European Urology Open Science |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666168320355646 |
id |
doaj-f89ff77d2a6e40e69e5f3f15fbb03ed8 |
---|---|
record_format |
Article |
spelling |
doaj-f89ff77d2a6e40e69e5f3f15fbb03ed82020-12-30T04:22:29ZengElsevierEuropean Urology Open Science2666-16832020-10-0120S142Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trialB. MarcoA. MartiniJ. PfailG. GandagliaN. FossatiS. ScuderiG. FallaraF. BarlettaD. RobestiA. RizzoG. BasileC.A. BraviG. RosielloL. NoceraA. StabileA. GallinaA. SaloniaF. MontorsiA. BrigantiM.D. GalskyW.K. Ohhttp://www.sciencedirect.com/science/article/pii/S2666168320355646 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
B. Marco A. Martini J. Pfail G. Gandaglia N. Fossati S. Scuderi G. Fallara F. Barletta D. Robesti A. Rizzo G. Basile C.A. Bravi G. Rosiello L. Nocera A. Stabile A. Gallina A. Salonia F. Montorsi A. Briganti M.D. Galsky W.K. Oh |
spellingShingle |
B. Marco A. Martini J. Pfail G. Gandaglia N. Fossati S. Scuderi G. Fallara F. Barletta D. Robesti A. Rizzo G. Basile C.A. Bravi G. Rosiello L. Nocera A. Stabile A. Gallina A. Salonia F. Montorsi A. Briganti M.D. Galsky W.K. Oh Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial European Urology Open Science |
author_facet |
B. Marco A. Martini J. Pfail G. Gandaglia N. Fossati S. Scuderi G. Fallara F. Barletta D. Robesti A. Rizzo G. Basile C.A. Bravi G. Rosiello L. Nocera A. Stabile A. Gallina A. Salonia F. Montorsi A. Briganti M.D. Galsky W.K. Oh |
author_sort |
B. Marco |
title |
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial |
title_short |
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial |
title_full |
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial |
title_fullStr |
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial |
title_full_unstemmed |
Surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the CHAARTED trial |
title_sort |
surrogate endpoints for overall survival for patients with metastatic hormone-sensitive prostate cancer in the chaarted trial |
publisher |
Elsevier |
series |
European Urology Open Science |
issn |
2666-1683 |
publishDate |
2020-10-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2666168320355646 |
work_keys_str_mv |
AT bmarco surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT amartini surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT jpfail surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT ggandaglia surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT nfossati surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT sscuderi surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT gfallara surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT fbarletta surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT drobesti surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT arizzo surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT gbasile surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT cabravi surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT grosiello surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT lnocera surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT astabile surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT agallina surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT asalonia surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT fmontorsi surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT abriganti surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT mdgalsky surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial AT wkoh surrogateendpointsforoverallsurvivalforpatientswithmetastatichormonesensitiveprostatecancerinthechaartedtrial |
_version_ |
1724366327309664256 |